Using NICE clinical guidelines and evidence from prior research (https://t.co/VzfeBPLXRx) we created positive predictive value (PPV) groups for different symptoms, including bands for 0.01-0.99%, 1-1.99%, 2-2.99%, 3-4.99%, >5%, to understand how PPV inf
@Dr_Sarah_Moore @UniofExeter asks the question if low risk cancer symptoms should be integrated into English guidance...i.e. result in earlier cancer detection... ...answer probably no on best available data. @BrJCancer: https://t.co/DBYfIZQXEI #sapcasm
New from #OfficialNIHR https://t.co/4XBp3Wpadi The impact of changing risk thresholds on the number of people in England eligible for urgent investigation for possible cancer: an observational cross-sectional study.
@Fredeolesen @SamMerriel @CanTest_PC @CRUKresearch @CRUKHCPs @CaPRINetwork @PC4TG @cancer_dk Especially in countries with strong gatekeeper function & lack access to diagnostics. Really interesting paper BJC from @BoomboomchiefsT @SarahDotPrice @Dr_Sar
The impact of changing risk thresholds on the number of people in England eligible for urgent investigation for possible cancer: an observational cross-sectional study https://t.co/vWC1bPmacf
RT @BoomboomchiefsT: have a dream... could we lower the NICE2015 3% threshold for urgent cancer investigation? https://t.co/rq5t49silu her…
RT @BoomboomchiefsT: have a dream... could we lower the NICE2015 3% threshold for urgent cancer investigation? https://t.co/rq5t49silu her…
Our estimation of the impact of reducing the referral threshold for urgent cancer investigation, out today in @BrJCancer
RT @BoomboomchiefsT: have a dream... could we lower the NICE2015 3% threshold for urgent cancer investigation? https://t.co/rq5t49silu her…
have a dream... could we lower the NICE2015 3% threshold for urgent cancer investigation? https://t.co/rq5t49silu here's what extra resources would be needed.... @Dr_Sarah_Moore @SarahDotPrice @exetermed